Recent events
| March 24-27, 2026 |
European Molecular Imaging Meeting, Ljubljana |
| March 12, 2026 |
Congratulation to Dr. Christian Ritschel for the H.C. Starck-Promotionspreis by GDCh |
| March 11-13, 2026 |
Hemdärmel-Kolloquium, University of Bonn |
| March 2, 2026 |
PaCaNano Project Meeting, University of Florence |
| February 27, 2026 | Congratulation to Matthias Steuer for Cotutelle PhD examination at Queensland University of Technology |
| February 25, 2026 |
Installation novel Dynamic Light Scattering Malvern Instruments Nanosizer Advance |
| February 24, 2026 | Installation novel Scanning Electron Microscope Zeiss Gemini 560 |
| February 2, 2026 | Congratulation to Matthias Steuer for PhD examination |
| November 4, 2024 | Nomination of Landes-Innovationspreis Niedersachsen for Start-up NanoDrug Delivery GmbH |
| October 25, 2024 | Congratulation to Andreas Reiß for passing PhD exam |
| September 19, 2024 | Wegbereiter-Award by Börsenclub Hannover for Start-up NanoDrug Delivery GmbH |
| September 16 - 18, 2024 | Inorganic Chemistry Conference of the GDCh, TU Munich (4 posters, 1 oral) |
| Start-up "NanoDrug Delivery GmbH" launched | |
| July 19, 2024 | Congratulation to Felix Jung for passing PhD exam |
| May 23, 2024 | "Wissenschaftspreis" (sponsored by Sartorius AG) & audience award for start-up "CaBiDi Drug Delivery UG" (represented by CEO Dr. D. Rudolph) Start-up Competition LIFT-OFF, Göttingen University |
| June 6, 2024 | Conversion / capital increase of start-up "CaBiDi Drug Delivery UG" to "NanoDrug Delivery GmbH" |
| June 13 - 16, 2024 | Hirschegg-Seminar on Solid-State Chemistry, Hirschegg, Austria |
| August 2, 2024 | Group excursion to "Lusoria Rhenana" (Roman river boat), Neupotz, Rhineland Palatinate |
| August 3, 2024 | Alumni meeting of the Feldmann group |
| August 7 - 9, 2024 | Hosting the PhD workshop "Nanotage" |
| December 15, 2024 | Congratulation to Maxime Bonnin for passing PhD exam |
Pancreatic cancer is one of the deadliest types of cancers in humans. It is the fourth leading cause of cancer-related deaths in the western world. The early stages of the disease often progress without symptoms, so diagnosis is usually very late. Another problem: Advanced tumors – and their metastases – can no longer be completely removed. Chemotherapies, in turn, attack not only the tumor cells but also healthy cells throughout the body. Innovative nanoparticles could be a new approach to treat cancer more precisely. The approach was developed by a research team from the Max Planck Institute (MPI) for Multidisciplinary Sciences, the University Medical Center Göttingen (UMG), and the Karlsruhe Institute of Technology (KIT). The therapy is now to be optimized for clinical application as quickly as possible.
learn more